Cite
HARVARD Citation
Mazeraud, A. et al. (2022). Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet. 10 (2), pp. 158-166. [Online].